“…Among the various compounds, pterostilbene (PTE), which is a methylated resveratrol derived from plants, has been shown to inhibit CSC properties in breast cancer [67,68], glioma [69], hepatocellular carcinoma [70], and lung cancer [71] through the inhibition of multiple pathways which are possibly related to the CSC propagation such as Wnt, Hedgehog, Notch, and PI3K/Akt. Honokiol (HNK), which is the extract from Magnolia obovata, has shown its various antitumor effects through the inhibition of several pathways such as PI3K/Akt/mTOR, Wnt, and c-Myc [72][73][74]. Besides these effects of PTE and HNK, we have identified that PTE in combination with HNK could be the possible metabolism-targeted therapy against osteosarcoma as a "two hit" or "dual inhibition" of metabolic pathways, OXPHOS and glycolysis.…”